Eleven-year-old child with COVID-19 induced long segment transverse myelitis
Main Article Content
Keywords
COVID-19, transverse myelitis
Abstract
Transverse myelitis (TM) is a clinical syndrome characterized by sensory, motor, and autonomic dysfunctions resulting from immune-mediated spinal cord injury. A possible association between COVID-19 and TM has been recognized. This paper examines the case of an eleven-year-old child who presented with paraplegia and urine retention and was evaluated carefully by a multidisciplinary team comprising a neurophysiologist, a pediatrician, and a neurologist. Sequentially, EMG, NCS, magnetic resonance T2 was conducted to reach the diagnosis of transverse myelitis. The patient was treated with bullous methylprednisolone for three days and showed steady and complete clinical and neurophysiological improvement.
References
2. Heinz FX, Stiasny K. Profiles of current COVID-19 vaccines. Wien
Klin Wochenschr. 2021;133(7–8):271–83. doi:10.1007/s00508-021- 01835-w.
3. Krishnan C, Kaplin AI, Deshpande DM, Pardo CA, Kerr DA. Transverse myelitis: pathogenesis, diagnosis and treatment. Front Biosci. 2004;9(2):1483–99.
4. Moreno-Escobar MC, Kataria S, Khan E, Subedi R, Tandon M, Peshwe K. Acute transverse myelitis with dysautonomia following SARS-CoV-2 infection: a case report and review of literature. J Neuroimmunol. 2021;353:577523.
5. Ahmad SA, Salih KH, Ahmed SF, et al. Post COVID-19 transverse myelitis: a case report with review of literature. Ann Med Surg (Lond). 2021;69:102749. doi:10.1016/j.amsu.2021.102749